000 01501 a2200433 4500
005 20250515153254.0
264 0 _c20090313
008 200903s 0 0 eng d
022 _a0891-3668
024 7 _a10.1097/INF.0b013e31818a5dbd
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFalagas, Matthew E
245 0 0 _aIntravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
_h[electronic resource]
260 _bThe Pediatric infectious disease journal
_cFeb 2009
300 _a123-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aColistin
_xadministration & dosage
650 0 4 _aCritical Illness
650 0 4 _aCystic Fibrosis
650 0 4 _aDrug Resistance, Multiple, Bacterial
650 0 4 _aFemale
650 0 4 _aGram-Negative Bacteria
_xdrug effects
650 0 4 _aGram-Negative Bacterial Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aInjections, Intravenous
650 0 4 _aMale
700 1 _aSideri, Georgia
700 1 _aVouloumanou, Evridiki K
700 1 _aPapadatos, John H
700 1 _aKafetzis, Dimitris A
773 0 _tThe Pediatric infectious disease journal
_gvol. 28
_gno. 2
_gp. 123-7
856 4 0 _uhttps://doi.org/10.1097/INF.0b013e31818a5dbd
_zAvailable from publisher's website
999 _c18566494
_d18566494